PHYLLIS WOOD: Open Payments
NPI 1881795854 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 6 payments from 5 companies in 2025. Trend: 2023 $706 · 2024 $704 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $223 |
| Corcept Therapeutics | 1 | $127 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $91 |
| Paratek Pharmaceuticals, Inc. | 1 | $54 |
Products named: Korlym, REXULTI, XIFAXAN, NUZYRA.
Industry payments across TX — which companies pay providers there.
